Dingco holds 28 granted patents, a Class I medical device manufacturing filing, a Class II medical device distribution filing, and multiple Class I device filings in China.
About Us
Founded in March 2024, Dingco Biotechnology focuses on the R&D, manufacturing and sales of automated pathology and cytology testing instruments, operating through two entities in Ningbo and Wuhan. The company runs a ~1,700 m² facility in Ningbo and a ~2,000 m² R&D and pilot-scale base in Wuhan. Of its ~40 employees, around 40% work in R&D and around 20% hold a master's degree or above.
Dual-Base Layout
Ningbo manufacturing base (~1,700 m²) · Wuhan R&D and pilot-scale base (~2,000 m²)
Qualifications & Intellectual Property
